APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Bisabolene

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Bisabolene Market Outlook and Growth Opportunities 2026

Report ID 173234100423 December 2025197 pages

Choose your research edition.

Industry ResearchBisabolene Industry Research Report 2026119 pages · $2,950 USDIndustry Growth & TrendsGlobal Bisabolene Industry Growth and Trends Forecast to 203293 pages · $3,450 USDMarket StructureGlobal Bisabolene Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032182 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Bisabolene Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Bisabolene Market Analysis and Forecast 2026-2032202 pages · $4,950 USD

Market perspective

The global Bisabolene market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Bisabolene is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Bisabolene is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Bisabolene is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Bisabolene market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Bisabolene market include BASF, Triveni Chemicals, Misri Fumet, Givaudan, Augustus Oils, Aurochemicals, Hairui Chemical and Hesheng Tech, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Bisabolene market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Bisabolene and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Bisabolene sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Bisabolene market size, projected growth trends, production technologies, key applications, and end-use industries.

Bisabolene Segment by Company

BASF

Triveni Chemicals

Misri Fumet

Givaudan

Augustus Oils

Aurochemicals

Hairui Chemical

Hesheng Tech

Bisabolene Segment by Type

γ-Bisabolene

β-Bisabolene

α-Bisabolene

Bisabolene Segment by Application

Cosmetic

Food

Pharmaceutical

Others

Bisabolene Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Bisabolene status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Bisabolene market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Bisabolene significant trends, drivers, influence factors in global and regions.

6. To analyze Bisabolene competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Bisabolene market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Bisabolene and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Bisabolene.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Bisabolene market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Bisabolene industry.

Chapter 3: Detailed analysis of Bisabolene manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Bisabolene in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Bisabolene in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Bisabolene Industry Trends Table 2. Bisabolene Industry Drivers Table 3. Bisabolene Industry Opportunities and Challenges Table 4. Bisabolene Industry Restraints Table 5. Global Bisabolene Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Bisabolene Revenue Share by Company (2021-2026) Table 7. Global Bisabolene Sales Volume by Company (Tons) & (2021-2026) Table 8. Global Bisabolene Sales Volume Share by Company (2021-2026) Table 9. Global Bisabolene Average Price (US$/Ton) of Company (2021-2026) Table 10. Global Bisabolene Company Ranking, (2024-2026) & (USD Million) Table 11. Global Bisabolene Key Company Manufacturing Base & Headquarters Table 12. Global Bisabolene Company, Product Type & Application Table 13. Global Bisabolene Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Bisabolene by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of γ-Bisabolene Table 18. Significant Companies of β-Bisabolene Table 19. Significant Companies of α-Bisabolene Table 20. Global Bisabolene Sales Volume by Type 2021 VS 2025 VS 2032 (Tons) Table 21. Global Bisabolene Sales Volume by Type (2021-2026) & (Tons) Table 22. Global Bisabolene Sales Volume by Type (2027-2032) & (Tons) Table 23. Global Bisabolene Sales Volume Share by Type (2021-2026) Table 24. Global Bisabolene Sales Volume Share by Type (2027-2032) Table 25. Global Bisabolene Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Bisabolene Sales Value by Type (2021-2026) & (US$ Million) Table 27. Global Bisabolene Sales Value by Type (2027-2032) & (US$ Million) Table 28. Global Bisabolene Sales Value Share by Type (2021-2026) Table 29. Global Bisabolene Sales Value Share by Type (2027-2032) Table 30. Significant Companies of Cosmetic Table 31. Significant Companies of Food Table 32. Significant Companies of Pharmaceutical Table 33. Significant Companies of Others Table 34. Global Bisabolene Sales Volume by Application 2021 VS 2025 VS 2032 (Tons) Table 35. Global Bisabolene Sales Volume by Application (2021-2026) & (Tons) Table 36. Global Bisabolene Sales Volume by Application (2027-2032) & (Tons) Table 37. Global Bisabolene Sales Volume Share by Application (2021-2026) Table 38. Global Bisabolene Sales Volume Share by Application (2027-2032) Table 39. Global Bisabolene Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 40. Global Bisabolene Sales Value by Application (2021-2026) & (US$ Million) Table 41. Global Bisabolene Sales Value by Application (2027-2032) & (US$ Million) Table 42. Global Bisabolene Sales Value Share by Application (2021-2026) Table 43. Global Bisabolene Sales Value Share by Application (2027-2032) Table 44. Global Bisabolene Sales by Region: 2021 VS 2025 VS 2032 (Tons) Table 45. Global Bisabolene Sales by Region (2021-2026) & (Tons) Table 46. Global Bisabolene Sales Market Share by Region (2021-2026) Table 47. Global Bisabolene Sales by Region (2027-2032) & (Tons) Table 48. Global Bisabolene Sales Market Share by Region (2027-2032) Table 49. Global Bisabolene Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 50. Global Bisabolene Sales Value by Region (2021-2026) & (US$ Million) Table 51. Global Bisabolene Sales Value Share by Region (2021-2026) Table 52. Global Bisabolene Sales Value by Region (2027-2032) & (US$ Million) Table 53. Global Bisabolene Sales Value Share by Region (2027-2032) Table 54. Global Bisabolene Market Average Price (US$/Ton) by Region (2021-2026) Table 55. Global Bisabolene Market Average Price (US$/Ton) by Region (2027-2032) Table 56. Global Bisabolene Sales by Country: 2021 VS 2025 VS 2032 (Tons) Table 57. Global Bisabolene Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 58. Global Bisabolene Sales by Country (2021-2026) & (Tons) Table 59. Global Bisabolene Sales Market Share by Country (2021-2026) Table 60. Global Bisabolene Sales by Country (2027-2032) & (Tons) Table 61. Global Bisabolene Sales Market Share by Country (2027-2032) Table 62. Global Bisabolene Sales Value by Country (2021-2026) & (US$ Million) Table 63. Global Bisabolene Sales Value Market Share by Country (2021-2026) Table 64. Global Bisabolene Sales Value by Country (2027-2032) & (US$ Million) Table 65. Global Bisabolene Sales Value Market Share by Country (2027-2032) Table 66. BASF Company Information Table 67. BASF Business Overview Table 68. BASF Bisabolene Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 69. BASF Bisabolene Product Portfolio Table 70. BASF Recent Development Table 71. Triveni Chemicals Company Information Table 72. Triveni Chemicals Business Overview Table 73. Triveni Chemicals Bisabolene Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 74. Triveni Chemicals Bisabolene Product Portfolio Table 75. Triveni Chemicals Recent Development Table 76. Misri Fumet Company Information Table 77. Misri Fumet Business Overview Table 78. Misri Fumet Bisabolene Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 79. Misri Fumet Bisabolene Product Portfolio Table 80. Misri Fumet Recent Development Table 81. Givaudan Company Information Table 82. Givaudan Business Overview Table 83. Givaudan Bisabolene Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 84. Givaudan Bisabolene Product Portfolio Table 85. Givaudan Recent Development Table 86. Augustus Oils Company Information Table 87. Augustus Oils Business Overview Table 88. Augustus Oils Bisabolene Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 89. Augustus Oils Bisabolene Product Portfolio Table 90. Augustus Oils Recent Development Table 91. Aurochemicals Company Information Table 92. Aurochemicals Business Overview Table 93. Aurochemicals Bisabolene Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 94. Aurochemicals Bisabolene Product Portfolio Table 95. Aurochemicals Recent Development Table 96. Hairui Chemical Company Information Table 97. Hairui Chemical Business Overview Table 98. Hairui Chemical Bisabolene Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 99. Hairui Chemical Bisabolene Product Portfolio Table 100. Hairui Chemical Recent Development Table 101. Hesheng Tech Company Information Table 102. Hesheng Tech Business Overview Table 103. Hesheng Tech Bisabolene Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 104. Hesheng Tech Bisabolene Product Portfolio Table 105. Hesheng Tech Recent Development Table 106. Key Raw Materials Table 107. Raw Materials Key Suppliers Table 108. Bisabolene Distributors List Table 109. Bisabolene Customers List Table 110. Research Programs/Design for This Report Table 111. Authors List of This Report Table 112. Secondary Sources Table 113. Primary Sources List of Figures Figure 1. Bisabolene Product Image Figure 2. Global Bisabolene Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Bisabolene Sales Value (2021-2032) & (US$ Million) Figure 4. Global Bisabolene Sales (2021-2032) & (Tons) Figure 5. Global Bisabolene Sales Average Price (US$/Ton) & (2021-2032) Figure 6. Global Bisabolene Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. γ-Bisabolene Image Figure 10. β-Bisabolene Image Figure 11. α-Bisabolene Image Figure 12. Global Bisabolene Sales Volume by Type (2021 VS 2025 VS 2032) & (Tons) Figure 13. Global Bisabolene Sales Volume Share 2021 VS 2025 VS 2032 Figure 14. Global Bisabolene Sales Volume Share by Type (2021-2032) Figure 15. Global Bisabolene Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Bisabolene Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Bisabolene Sales Value Share by Type (2021-2032) Figure 18. Cosmetic Image Figure 19. Food Image Figure 20. Pharmaceutical Image Figure 21. Others Image Figure 22. Global Bisabolene Sales Volume by Application (2021 VS 2025 VS 2032) & (Tons) Figure 23. Global Bisabolene Sales Volume Share 2021 VS 2025 VS 2032 Figure 24. Global Bisabolene Sales Volume Share by Application (2021-2032) Figure 25. Global Bisabolene Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 26. Global Bisabolene Sales Value Share 2021 VS 2025 VS 2032 Figure 27. Global Bisabolene Sales Value Share by Application (2021-2032) Figure 28. Global Bisabolene Sales by Region: 2021 VS 2025 VS 2032 (Tons) Figure 29. Global Bisabolene Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 30. Global Bisabolene Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 31. Global Bisabolene Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 32. North America Bisabolene Sales Value (2021-2032) & (US$ Million) Figure 33. North America Bisabolene Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Europe Bisabolene Sales Value (2021-2032) & (US$ Million) Figure 35. Europe Bisabolene Sales Value Share by Country (%), 2025 VS 2032 Figure 36. Asia-Pacific Bisabolene Sales Value (2021-2032) & (US$ Million) Figure 37. Asia-Pacific Bisabolene Sales Value Share by Country (%), 2025 VS 2032 Figure 38. South America Bisabolene Sales Value (2021-2032) & (US$ Million) Figure 39. South America Bisabolene Sales Value Share by Country (%), 2025 VS 2032 Figure 40. Middle East & Africa Bisabolene Sales Value (2021-2032) & (US$ Million) Figure 41. Middle East & Africa Bisabolene Sales Value Share by Country (%), 2025 VS 2032 Figure 42. USA Bisabolene Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. USA Bisabolene Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. USA Bisabolene Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. Canada Bisabolene Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. Canada Bisabolene Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. Canada Bisabolene Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Mexico Bisabolene Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Mexico Bisabolene Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Mexico Bisabolene Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Germany Bisabolene Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Germany Bisabolene Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Germany Bisabolene Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. France Bisabolene Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. France Bisabolene Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. France Bisabolene Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. U.K. Bisabolene Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. U.K. Bisabolene Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. U.K. Bisabolene Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Italy Bisabolene Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Italy Bisabolene Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Italy Bisabolene Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Spain Bisabolene Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Spain Bisabolene Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Spain Bisabolene Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Russia Bisabolene Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Russia Bisabolene Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Russia Bisabolene Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Netherlands Bisabolene Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Netherlands Bisabolene Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Netherlands Bisabolene Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. Nordic Countries Bisabolene Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. Nordic Countries Bisabolene Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. Nordic Countries Bisabolene Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. China Bisabolene Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. China Bisabolene Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. China Bisabolene Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Japan Bisabolene Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Japan Bisabolene Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Japan Bisabolene Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. South Korea Bisabolene Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. South Korea Bisabolene Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. South Korea Bisabolene Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. India Bisabolene Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. India Bisabolene Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. India Bisabolene Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Australia Bisabolene Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Australia Bisabolene Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Australia Bisabolene Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Southeast Asia Bisabolene Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Southeast Asia Bisabolene Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Southeast Asia Bisabolene Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Brazil Bisabolene Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Brazil Bisabolene Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Brazil Bisabolene Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Argentina Bisabolene Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Argentina Bisabolene Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Argentina Bisabolene Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Chile Bisabolene Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Chile Bisabolene Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Chile Bisabolene Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Colombia Bisabolene Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Colombia Bisabolene Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Colombia Bisabolene Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Peru Bisabolene Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Peru Bisabolene Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Peru Bisabolene Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Bisabolene Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Saudi Arabia Bisabolene Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Saudi Arabia Bisabolene Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Israel Bisabolene Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Israel Arabia Bisabolene Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Israel Arabia Bisabolene Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. UAE Bisabolene Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. UAE Bisabolene Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. UAE Bisabolene Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Turkey Bisabolene Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 118. Turkey Bisabolene Sales Value Share by Type, 2025 VS 2032 & (%) Figure 119. Turkey Bisabolene Sales Value Share by Application, 2025 VS 2032 & (%) Figure 120. Iran Bisabolene Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 121. Iran Bisabolene Sales Value Share by Type, 2025 VS 2032 & (%) Figure 122. Iran Bisabolene Sales Value Share by Application, 2025 VS 2032 & (%) Figure 123. Egypt Bisabolene Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 124. Egypt Bisabolene Sales Value Share by Type, 2025 VS 2032 & (%) Figure 125. Egypt Bisabolene Sales Value Share by Application, 2025 VS 2032 & (%) Figure 126. Bisabolene Value Chain Figure 127. Manufacturing Cost Structure Figure 128. Bisabolene Sales Mode & Process Figure 129. Direct Comparison with Distribution Share Figure 130. Distributors Profiles Figure 131. Years Considered Figure 132. Research Process Figure 133. Key Executives Interviewed

Scope & coverage.

Types
  • γ-Bisabolene
  • β-Bisabolene
  • α-Bisabolene
Applications
  • Cosmetic
  • Food
  • Pharmaceutical
  • Others
Companies covered
  • BASF
  • Triveni Chemicals
  • Misri Fumet
  • Givaudan
  • Augustus Oils
  • Aurochemicals
  • Hairui Chemical
  • Hesheng Tech

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Bisabolene Sales Value (2021-2032)
  4. 1.2.2 Global Bisabolene Sales Volume (2021-2032)
  5. 1.2.3 Global Bisabolene Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Bisabolene Market Dynamics
  1. 2.1 Bisabolene Industry Trends
  2. 2.2 Bisabolene Industry Drivers
  3. 2.3 Bisabolene Industry Opportunities and Challenges
  4. 2.4 Bisabolene Industry Restraints
3 Bisabolene Market by Company
  1. 3.1 Global Bisabolene Company Revenue Ranking in 2025
  2. 3.2 Global Bisabolene Revenue by Company (2021-2026)
  3. 3.3 Global Bisabolene Sales Volume by Company (2021-2026)
  4. 3.4 Global Bisabolene Average Price by Company (2021-2026)
  5. 3.5 Global Bisabolene Company Ranking (2024-2026)
  6. 3.6 Global Bisabolene Company Manufacturing Base and Headquarters
  7. 3.7 Global Bisabolene Company Product Type and Application
  8. 3.8 Global Bisabolene Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Bisabolene Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Bisabolene Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Bisabolene Market by Type
  1. 4.1 Bisabolene Type Introduction
  2. 4.1.1 γ-Bisabolene
  3. 4.1.2 β-Bisabolene
  4. 4.1.3 α-Bisabolene
  5. 4.2 Global Bisabolene Sales Volume by Type
  6. 4.2.1 Global Bisabolene Sales Volume by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Bisabolene Sales Volume by Type (2021-2032)
  8. 4.2.3 Global Bisabolene Sales Volume Share by Type (2021-2032)
  9. 4.3 Global Bisabolene Sales Value by Type
  10. 4.3.1 Global Bisabolene Sales Value by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Bisabolene Sales Value by Type (2021-2032)
  12. 4.3.3 Global Bisabolene Sales Value Share by Type (2021-2032)
5 Bisabolene Market by Application
  1. 5.1 Bisabolene Application Introduction
  2. 5.1.1 Cosmetic
  3. 5.1.2 Food
  4. 5.1.3 Pharmaceutical
  5. 5.1.4 Others
  6. 5.2 Global Bisabolene Sales Volume by Application
  7. 5.2.1 Global Bisabolene Sales Volume by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Bisabolene Sales Volume by Application (2021-2032)
  9. 5.2.3 Global Bisabolene Sales Volume Share by Application (2021-2032)
  10. 5.3 Global Bisabolene Sales Value by Application
  11. 5.3.1 Global Bisabolene Sales Value by Application (2021 VS 2025 VS 2032)
  12. 5.3.2 Global Bisabolene Sales Value by Application (2021-2032)
  13. 5.3.3 Global Bisabolene Sales Value Share by Application (2021-2032)
6 Bisabolene Regional Sales and Value Analysis
  1. 6.1 Global Bisabolene Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Bisabolene Sales by Region (2021-2032)
  3. 6.2.1 Global Bisabolene Sales by Region: 2021-2026
  4. 6.2.2 Global Bisabolene Sales by Region (2027-2032)
  5. 6.3 Global Bisabolene Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Bisabolene Sales Value by Region (2021-2032)
  7. 6.4.1 Global Bisabolene Sales Value by Region: 2021-2026
  8. 6.4.2 Global Bisabolene Sales Value by Region (2027-2032)
  9. 6.5 Global Bisabolene Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Bisabolene Sales Value (2021-2032)
  12. 6.6.2 North America Bisabolene Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Bisabolene Sales Value (2021-2032)
  15. 6.7.2 Europe Bisabolene Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Bisabolene Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Bisabolene Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Bisabolene Sales Value (2021-2032)
  21. 6.9.2 South America Bisabolene Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Bisabolene Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Bisabolene Sales Value Share by Country, 2025 VS 2032
7 Bisabolene Country-level Sales and Value Analysis
  1. 7.1 Global Bisabolene Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Bisabolene Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Bisabolene Sales by Country (2021-2032)
  4. 7.3.1 Global Bisabolene Sales by Country (2021-2026)
  5. 7.3.2 Global Bisabolene Sales by Country (2027-2032)
  6. 7.4 Global Bisabolene Sales Value by Country (2021-2032)
  7. 7.4.1 Global Bisabolene Sales Value by Country (2021-2026)
  8. 7.4.2 Global Bisabolene Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Bisabolene Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Bisabolene Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Bisabolene Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Bisabolene Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Bisabolene Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Bisabolene Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Bisabolene Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Bisabolene Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Bisabolene Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Bisabolene Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Bisabolene Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Bisabolene Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Bisabolene Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Bisabolene Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Bisabolene Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Bisabolene Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Bisabolene Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Bisabolene Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Bisabolene Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Bisabolene Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Bisabolene Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Bisabolene Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Bisabolene Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Bisabolene Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Bisabolene Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Bisabolene Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Bisabolene Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Bisabolene Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Bisabolene Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Bisabolene Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Bisabolene Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Bisabolene Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Bisabolene Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Bisabolene Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Bisabolene Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Bisabolene Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Bisabolene Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Bisabolene Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Bisabolene Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Bisabolene Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Bisabolene Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Bisabolene Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Bisabolene Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Bisabolene Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Bisabolene Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Bisabolene Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Bisabolene Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Bisabolene Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Bisabolene Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Bisabolene Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Bisabolene Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Bisabolene Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Bisabolene Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Bisabolene Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Bisabolene Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Bisabolene Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Bisabolene Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Bisabolene Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Bisabolene Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Bisabolene Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Bisabolene Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Bisabolene Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Bisabolene Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Bisabolene Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Bisabolene Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Bisabolene Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Bisabolene Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Bisabolene Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Bisabolene Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Bisabolene Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Bisabolene Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Bisabolene Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Bisabolene Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Bisabolene Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Bisabolene Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Bisabolene Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Bisabolene Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Bisabolene Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Bisabolene Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Bisabolene Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Bisabolene Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Bisabolene Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Bisabolene Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Bisabolene Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 BASF
  2. 8.1.1 BASF Company Information
  3. 8.1.2 BASF Business Overview
  4. 8.1.3 BASF Bisabolene Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 BASF Bisabolene Product Portfolio
  6. 8.1.5 BASF Recent Developments
  7. 8.2 Triveni Chemicals
  8. 8.2.1 Triveni Chemicals Company Information
  9. 8.2.2 Triveni Chemicals Business Overview
  10. 8.2.3 Triveni Chemicals Bisabolene Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Triveni Chemicals Bisabolene Product Portfolio
  12. 8.2.5 Triveni Chemicals Recent Developments
  13. 8.3 Misri Fumet
  14. 8.3.1 Misri Fumet Company Information
  15. 8.3.2 Misri Fumet Business Overview
  16. 8.3.3 Misri Fumet Bisabolene Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Misri Fumet Bisabolene Product Portfolio
  18. 8.3.5 Misri Fumet Recent Developments
  19. 8.4 Givaudan
  20. 8.4.1 Givaudan Company Information
  21. 8.4.2 Givaudan Business Overview
  22. 8.4.3 Givaudan Bisabolene Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Givaudan Bisabolene Product Portfolio
  24. 8.4.5 Givaudan Recent Developments
  25. 8.5 Augustus Oils
  26. 8.5.1 Augustus Oils Company Information
  27. 8.5.2 Augustus Oils Business Overview
  28. 8.5.3 Augustus Oils Bisabolene Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Augustus Oils Bisabolene Product Portfolio
  30. 8.5.5 Augustus Oils Recent Developments
  31. 8.6 Aurochemicals
  32. 8.6.1 Aurochemicals Company Information
  33. 8.6.2 Aurochemicals Business Overview
  34. 8.6.3 Aurochemicals Bisabolene Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Aurochemicals Bisabolene Product Portfolio
  36. 8.6.5 Aurochemicals Recent Developments
  37. 8.7 Hairui Chemical
  38. 8.7.1 Hairui Chemical Company Information
  39. 8.7.2 Hairui Chemical Business Overview
  40. 8.7.3 Hairui Chemical Bisabolene Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Hairui Chemical Bisabolene Product Portfolio
  42. 8.7.5 Hairui Chemical Recent Developments
  43. 8.8 Hesheng Tech
  44. 8.8.1 Hesheng Tech Company Information
  45. 8.8.2 Hesheng Tech Business Overview
  46. 8.8.3 Hesheng Tech Bisabolene Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Hesheng Tech Bisabolene Product Portfolio
  48. 8.8.5 Hesheng Tech Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Bisabolene Value Chain Analysis
  2. 9.1.1 Bisabolene Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Bisabolene Sales Mode & Process
  6. 9.2 Bisabolene Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Bisabolene Distributors
  9. 9.2.3 Bisabolene Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst